RecruitingN/AOther

Induction Agent Choice With Early Mortality and Prognostic Outcomes in Critically Ill Patients

Sponsored by Zeliha Alicikus

NCT ID
NCT07222007
Target Enrollment
4 participants
Start Date
2026-02-18
Est. Completion
2026-07-01

About This Study

The aim of this retrospective cohort study is to compare the safety and efficacy of induction agents for tracheal intubation in critically ill adult patients.

Conditions Studied

Critically IllIntubation ComplicationOxygenationAirway ManagementPropofolKetamine

Interventions

  • induction type for intubation in ICU

Eligibility

Age:18 Years - N/A
Healthy Volunteers:No
View full eligibility criteria
Inclusion Criteria:

* Age ≥ 18 years
* Admission to the surgical ICU for critical care
* Administration of one of the studied induction agents
* Availability of complete clinical data

Exclusion Criteria:

* Age \< 18 years
* Absence of documented induction agent administration
* Incomplete or missing medical records

Study Locations (1)

UF Health Jacksonville (Shands Hospital)
Jacksonville, Florida, United States

Interested in this trial?

Contact the study team to learn more about eligibility and enrollment.

TOLGA SARAÇOĞLU, Prof,MD
CONTACT
+1 (904) 524-5932kemaltolgasaracoglu@gmail.com
Tolga Saraçoğlu, Asc Prof,MD
CONTACT
+1 (904) 524-5932kemaltolgasaracoglu@gmail.com
View on ClinicalTrials.gov
Data Source
ClinicalTrials.gov

Last updated from source